Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Rathod

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Microbiology|April 16, 2025
Genotypic and phenotypic characterization of virulence in methicillin resistant Staphylococcus aureus isolated from a local hospital of Ahmedabad, Gujarat, IndiaHardi Patel, Aakruti Patel, Ravi Chauhan, et al.
The Journal of Contemporary Dental Practice|May 9, 2020
<i>In Vitro</i> Analysis of Licorice (<i>Glycyrrhiza glabra</i>) Root Extract Activity on <i>Streptococcus mutans</i> in Comparison to Chlorhexidine and Fluoride MouthwashEkta A Malvania, Ashish S Sharma, Sona A Sheth, et al.
Acta Pharmaceutica Sinica. B|January 13, 2022
Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in miceGundala Venkata Naveen Kumar, Keito Hoshitsuki, Sanjay Rathod, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2017
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapyJingjing Sun, Yanhua Liu, Yichao Chen, et al.
BMJ Open|January 6, 2021
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional studyOm Prakash, Bhavin Solanki, Jay K Sheth, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophagesPearl Moharil, Zhuoya Wan, Apurva Pardeshi, et al.
Frontiers in Pharmacology|January 24, 2025
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicityAboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, et al.
Disease-A-Month : DM|March 24, 2020
Antimicrobial resistance, mechanisms and its clinical significanceManar Ali Abushaheen, Muzaheed, Amal Jamil Fatani, et al.
Science Advances|February 11, 2021
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistanceWeiwei Guo, Yue Wang, Min Yang, et al.
The Journal of Infectious Diseases|March 10, 2022
Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019Priscila M S Castanha, Dylan J Tuttle, Georgios D Kitsios, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Microbiology|April 16, 2025
Genotypic and phenotypic characterization of virulence in methicillin resistant Staphylococcus aureus isolated from a local hospital of Ahmedabad, Gujarat, IndiaHardi Patel, Aakruti Patel, Ravi Chauhan, et al.
The Journal of Contemporary Dental Practice|May 9, 2020
<i>In Vitro</i> Analysis of Licorice (<i>Glycyrrhiza glabra</i>) Root Extract Activity on <i>Streptococcus mutans</i> in Comparison to Chlorhexidine and Fluoride MouthwashEkta A Malvania, Ashish S Sharma, Sona A Sheth, et al.
Acta Pharmaceutica Sinica. B|January 13, 2022
Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in miceGundala Venkata Naveen Kumar, Keito Hoshitsuki, Sanjay Rathod, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2017
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapyJingjing Sun, Yanhua Liu, Yichao Chen, et al.
BMJ Open|January 6, 2021
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional studyOm Prakash, Bhavin Solanki, Jay K Sheth, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophagesPearl Moharil, Zhuoya Wan, Apurva Pardeshi, et al.
Frontiers in Pharmacology|January 24, 2025
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicityAboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, et al.
Disease-A-Month : DM|March 24, 2020
Antimicrobial resistance, mechanisms and its clinical significanceManar Ali Abushaheen, Muzaheed, Amal Jamil Fatani, et al.
Science Advances|February 11, 2021
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistanceWeiwei Guo, Yue Wang, Min Yang, et al.
The Journal of Infectious Diseases|March 10, 2022
Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019Priscila M S Castanha, Dylan J Tuttle, Georgios D Kitsios, et al.
Pageof 2